First Light Asset Management, LLC and Mathew P. Arens jointly filed Amendment No. 2 to a Schedule 13G with the SEC on November 16, 2026, disclosing beneficial ownership of shares in TriSalus Life Sciences, Inc. (NASDAQ:TLSI) as of September 30, 2026.
Key Highlights
- Aggregate beneficial ownership: Both First Light Asset Management, LLC and Mathew P. Arens each reported beneficial ownership of 7,405,486 shares of TriSalus Life Sciences common stock.
- Percent of class: The 7,405,486 shares represent 12.0% of the outstanding class, according to the filing.
- No sole voting or dispositive power: Each reporting person disclosed 0 shares with sole voting power and 0 shares with sole dispositive power.
- Shared voting and dispositive power: All 7,405,486 shares are held with shared voting power and shared dispositive power by each reporting person.
- Event date: The date of the event requiring the filing is listed as September 30, 2026.
- Filer roles: First Light Asset Management, LLC is classified as an investment adviser; Mathew P. Arens is identified as managing member and majority owner of the Manager.
First Light and Arens Disclose Joint 12% Position in TriSalus Life Sciences
According to the filing, First Light Asset Management, LLC, a Delaware limited liability company based at 3300 Edinborough Way, Suite 201, Edina, MN 55435, and Mathew P. Arens, a United States citizen, jointly submitted Amendment No. 2 to Schedule 13G covering common stock of TriSalus Life Sciences, Inc., which has its principal executive offices at 6272 W. 91st Ave., Westminster, CO 80031. The securities covered are shares of common stock with a par value of $0.01, identified by CUSIP number 89680M101.
The filing states that First Light Asset Management, LLC "acts as an investment adviser to certain persons holding separately managed accounts with the Manager, each of whom has the right to receive or the power to direct the receipt of dividends from, or the proceeds from the sale of, those shares." The filing further states the Manager "may also be deemed to be the beneficial owner of these shares because it acts as an investment adviser to certain private funds." Mathew P. Arens "may also be deemed to be the beneficial owner of these shares because he controls the Manager in his position as managing member and majority owner of the Manager."
The filing was made pursuant to Rule 13d-1(b) under the Securities Exchange Act of 1934. Both reporting persons certified that the securities "were acquired and are held in the ordinary course of business and were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer." The filing was signed by Kurt T. Peterson, Chief Compliance Officer of First Light Asset Management, LLC, and by Mathew P. Arens in his capacity as Chief Executive Officer, both dated November 16, 2026.
What Was Disclosed
First Light Asset Management, LLC and Mathew P. Arens filed Amendment No. 2 to Schedule 13G disclosing that each beneficially owns 7,405,486 shares, or 12.0%, of TriSalus Life Sciences, Inc. common stock, with all shares held under shared voting and dispositive power as of September 30, 2026.




Please wait processing your request...